HHLR Advisors (Hillhouse)

Superinvestor

HHLR Advisors, Ltd.

SEC CIK: 0001762304
Manager: Zhang Lei
Style: Growth
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

FDMT holding history

4D Molecular Therapeutics, Inc. in every 13F filed by HHLR Advisors (Hillhouse), including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FDMT overview All 13F holders of FDMT Full Q2 2026 holdings

Shares (Q2 2021): 0; Sold out in Q2 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2021

Holdings of FDMT by HHLR Advisors (Hillhouse), by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2021	0	$0	0.0%	−157,500−100.0%	Sold out	Holders
Q1 2021	157,500	$6.83M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.